Search

Your search keyword '"Cao, Davide"' showing total 575 results

Search Constraints

Start Over You searched for: Author "Cao, Davide" Remove constraint Author: "Cao, Davide"
575 results on '"Cao, Davide"'

Search Results

2. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease

4. 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program

5. Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials

6. Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review

7. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention

8. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI

9. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention

10. Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions

11. Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries)

12. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT

14. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent

15. One- Versus Three-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease

19. Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention

21. Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI

22. Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction

23. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.

26. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI

27. Beyond the GRACE ACS Score: Do We Need a Different Model for Men and Women after STEMI?

28. Além do Escore GRACE SCA: É Necessário um Modelo Diferente para Homens e Mulheres após IAMCSST?

29. Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI

30. Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies

33. Abstract 14790: Impact of Pre-Frailty and Frailty in Women Undergoing TAVR: Insights From the WIN-TAVI Registry

34. Abstract 12805: Incidence and Predictors of Myocardial Infarction or Stent Thrombosis in High-Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention

35. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

37. Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents

40. Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery

41. TCT-168 Clinical Significance of Insulin- and Noninsulin-Dependent Diabetes in Patients Undergoing Percutaneous Revascularization of the Left Main Coronary Artery

43. Management of Adults With Anomalous Aortic Origin of the Coronary Arteries

44. TCT-433 Clinical and Procedural Outcomes of Percutaneous Coronary Intervention for De Novo Lesions involving the Ostial Left Circumflex Coronary Artery

45. Anaemia and transfusion

47. Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention.

49. Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study

Catalog

Books, media, physical & digital resources